No association between chronic use of ranitidine, compared with omeprazole or famotidine, and gastrointestinal malignancies-Reference-Cited by-同舟云学术

No association between chronic use of ranitidine, compared with omeprazole or famotidine, and gastrointestinal malignancies

Published:2021-07-12 Issue:5 Volume:54 Page:606-615
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Kim Yeseong D.¹^ORCID,Wang Jiasheng¹,Shibli Fahmi²,Poels Kamrine E.³,Ganocy Stephen J.⁴,Fass Ronnie²

Affiliation:

1. Department of Internal Medicine MetroHealth Medical CenterCase Western Reserve University Cleveland OH USA

2. Division of Gastroenterology and Hepatology The Oesophageal and Swallowing CenterCase Western Reserve UniversityMetroHealth Medical Center Cleveland OH USA

3. Department of Biostatistics Harvard T.H. Chan School of Public Health Boston MA USA

4. Data Management and Statistical Analysis Unit Mood Disorders Program University Hospitals Case Medical CenterCase Western Reserve University Cleveland OH USA

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/apt.16464

Reference30 articles.

1. Gastro-Oesophageal Reflux Disease

2. The use of H2 antagonists in treating and preventing NSAID-induced mucosal damage

3. Contemporary medical therapy for gastroesophageal reflux disease;Fass R;Am Fam Physician,1997

4. Ranitidine: A New H2-Receptor Antagonist

5. The effectiveness of ranitidine in reducing gastric acid-secretion decreases with continued therapy.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk assessment of N‐nitrosamines in food;EFSA Journal;2023-03

2. Prescription changes in patients with gastrointestinal disorders after withdrawal of ranitidine: a nationwide population-based cohort study;Current Medical Research and Opinion;2023-01-03

3. Meta‐analysis: Use of proton pump inhibitors and risk of gastric cancer in patients requiring gastric acid suppression;Alimentary Pharmacology & Therapeutics;2022-12-31

4. Association between ranitidine use with potential NDMA impurities and risk of cancer in Korea;Scientific Reports;2022-12-27

5. Effect of Ranitidine Intake on the Risk of Gastric Cancer Development;Healthcare;2021-08-20